Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Escuin-Ordinas

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Oncotargets and Therapy|April 5, 2016
Tremelimumab: research and clinical developmentBegoña Comin-Anduix, Helena Escuin-Ordinas, Francisco Javier Ibarrondo
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 12, 2018
Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly(propylene sulfide) scaffolds loaded with poorly water-soluble drugsSuwei Zhu, Shuoran Li, Helena Escuin-Ordinas, et al.
Nucleic Acids Research|December 6, 2011
2A peptides provide distinct solutions to driving stop-carry on translational recodingPamila Sharma, Fu Yan, Victoria A Doronina, et al.
Molecular Biology and Evolution|June 4, 2013
APE-type non-LTR retrotransposons of multicellular organisms encode virus-like 2A oligopeptide sequences, which mediate translational recoding during protein synthesisValerie Odon, Garry A Luke, Claire Roulston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrationsBegoña Comin-Anduix, Thinle Chodon, Hooman Sazegar, et al.
Cancer Research|November 18, 2015
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to ImmunotherapyRichard Tavaré, Helena Escuin-Ordinas, Stephen Mok, et al.
Plos One|September 22, 2010
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanomaBegoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, et al.
Molecular Cancer|February 4, 2015
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanomaMohammad Atefi, Bjoern Titz, Earl Avramis, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibodyHelena Escuin-Ordinas, Mark W Elliott, Mohammad Atefi, et al.
Cancer Immunology Research|May 6, 2014
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and functionDeborah J L Wong, Amol Rao, Earl Avramis, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Oncotargets and Therapy|April 5, 2016
Tremelimumab: research and clinical developmentBegoña Comin-Anduix, Helena Escuin-Ordinas, Francisco Javier Ibarrondo
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 12, 2018
Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly(propylene sulfide) scaffolds loaded with poorly water-soluble drugsSuwei Zhu, Shuoran Li, Helena Escuin-Ordinas, et al.
Nucleic Acids Research|December 6, 2011
2A peptides provide distinct solutions to driving stop-carry on translational recodingPamila Sharma, Fu Yan, Victoria A Doronina, et al.
Molecular Biology and Evolution|June 4, 2013
APE-type non-LTR retrotransposons of multicellular organisms encode virus-like 2A oligopeptide sequences, which mediate translational recoding during protein synthesisValerie Odon, Garry A Luke, Claire Roulston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrationsBegoña Comin-Anduix, Thinle Chodon, Hooman Sazegar, et al.
Cancer Research|November 18, 2015
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to ImmunotherapyRichard Tavaré, Helena Escuin-Ordinas, Stephen Mok, et al.
Plos One|September 22, 2010
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanomaBegoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, et al.
Molecular Cancer|February 4, 2015
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanomaMohammad Atefi, Bjoern Titz, Earl Avramis, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibodyHelena Escuin-Ordinas, Mark W Elliott, Mohammad Atefi, et al.
Cancer Immunology Research|May 6, 2014
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and functionDeborah J L Wong, Amol Rao, Earl Avramis, et al.
Pageof 2